Waystar Reports Fourth Quarter and Fiscal Year 2024 Results
Fiscal year 2024 revenue of $944M, up 19% YoY
Q4 revenue growth of 18% year-over-year
Q4 net income of $19.1 million and non-GAAP net income of $52.1 million
Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY
Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY
Q4 net income margin of 8%; adjusted EBITDA margin of 41%
LEHI, Utah and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024.
"We are pleased to report strong results for the fourth quarter and full year 2024, exceeding expectations and reflecting the successful execution of our strategic priorities," said Matt Hawkins, Chief Executive Officer of Waystar. "By leveraging the power of our cloud-based software platform, we have consistently delivered measurable return on investment for our clients."
Hawkins continued, "Looking ahead, we expect to achieve solid revenue growth at scale, paired with compelling adjusted EBITDA margins, positioning us for continued success."
Fourth Quarter 2024 Financial Highlights
-- Revenue of $244.1 million, up 18% year-over-year
-- Net income of $19.1 million, GAAP net income per share of $0.11, and net
income margin of 8%
-- Non-GAAP net income of $52.1 million and non-GAAP net income per diluted
share of $0.29
-- Adjusted EBITDA of $100.2 million and adjusted EBITDA margin of 41%
-- Cash flow from operations of $65 million and unlevered free cash flow of
$80 million
Key Metrics and Revenue Disaggregation
-- 1,203 clients contributed over $100,000 in LTM revenue, up 15%
year-over-year
-- Net revenue retention rate (NRR) of 110%
-- Subscription revenue of $121.6 million, up 18% year-over-year
-- Volume-based revenue of $121.2 million, up 19% year-over-year
Financial Outlook
As of February 18, 2025, Waystar provides the following guidance for its full fiscal year 2025.(1)
-- Total revenue is expected to be between $1.0 billion and $1.016 billion
-- Adjusted EBITDA is expected to be between $399 million and $407 million
-- Non-GAAP net income is expected to be between $237 million and $243
million
-- Diluted non-GAAP net income per share is expected to be between $1.29
and $1.32
Webcast Information
Waystar's financial results will be discussed on a conference call scheduled at 8:30 a.m. Eastern Standard Time today, February 18, 2025. A live audio conference call will be available on Waystar's website at https://investors.waystar.com/news-events/events. The webcast will be archived on the site for those unable to listen in real time. This earnings release and the related Current Report on Form 8-K filed February 18, 2025 can be accessed on the Investor Relations page of the company's website. We routinely post important information on our website, including corporate and investor presentations and financial information. We intend to use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included in the Investor Relations section of our website. Accordingly, investors should monitor this portion of our website, in addition to following our press releases, U.S. Securities and Exchange Commission ("SEC") filings, and public conference calls and webcasts.
Non-GAAP Financial Measures
To supplement the consolidated financial statements prepared and presented in accordance with U.S. generally accepted accounting principles ("GAAP"), this press release contains certain non-GAAP financial measures as defined below. We present non-GAAP financial measures as supplemental measures of financial performance that are not required by, or presented in accordance with, GAAP. We believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes these non-GAAP financial measures are useful to investors in highlighting trends in our operating performance, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate, and capital investments. Management uses adjusted EBITDA and adjusted EBITDA margin to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation, and to compare our performance against that of other peer companies using similar measures. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone provide.
Adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per share and unlevered free cash flow are not recognized terms under GAAP and should not be considered as an alternative to net income (loss) or net income (loss) margin as measures of financial performance or cash provided by operating activities as a measure of liquidity, or any other performance measure derived in accordance with GAAP. Additionally, these measures are not intended to be a measure of free cash flow available for management's discretionary use, as they do not consider certain cash requirements such as interest payments, tax payments, and debt service requirements. The presentations of these measures have limitations as analytical tools and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company. A reconciliation is provided below for our non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review the related GAAP financial measures and the reconciliation of non-GAAP financial measures to their most directly comparable GAAP financial measures, and not to rely on any single financial measure to evaluate our business.
The following non-GAAP financial measures and key performance metrics are defined below:
Adjusted EBITDA and adjusted EBITDA Margin
We define adjusted EBITDA as net loss before interest expense, net income tax benefit, depreciation and amortization, and as further adjusted for stock-based compensation expense, acquisition and integration costs, asset and lease impairments, costs related to amended debt agreements, and IPO related costs. Adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.
Non-GAAP Net Income and Non-GAAP Net Income Per Share
We define non-GAAP net income as GAAP net income excluding the impact of stock-based compensation, acquisition and integration costs, asset and lease impairments, IPO related costs, costs related to amended debt agreements and amortization of intangibles. We updated the definition of non-GAAP net income to include amortization of intangibles to align with a more common definition used by our peers. We have revised prior year disclosures to align with this updated definition. The tax effects of the adjustments are calculated using a management-estimated annual effective non-GAAP tax rate of 21%.
We define non-GAAP net income per share as non-GAAP net income (loss) divided by weighted-average shares used to compute net loss per share.
Unlevered Free Cash Flow
We define unlevered free cash flow as cash from operations plus cash interest expense less capital expenses.
Net Debt
We define net debt as the sum of the current portion of long-term debt, long-term debt, and accounts receivable securitization less cash and equivalents.
Adjusted Net Leverage Ratio
We define adjusted net leverage ratio as net debt divided by adjusted EBITDA over the preceding twelve months.
Key Performance Metrics
Net Revenue Retention Rate
Our Net Revenue Retention Rate compares twelve months of client invoices for our solutions at two period end dates. To calculate our Net Revenue Retention Rate, we first accumulate the total amount invoiced during the twelve months ending with the prior period-end or Prior Period Invoices. We then calculate the total amount invoiced to those same clients for the twelve months ending with the current period-end, or Current Period Invoices. Current Period Invoices are inclusive of upsell, downsell, pricing changes, clients that cancel or chose not to renew, and discontinued solutions with continuing clients. The Net Revenue Retention Rate is then calculated by dividing the Current Period Invoices by the Prior Period Invoices. Our total invoices included in the analysis are greater than 98% of reported revenue. We use Net Revenue Retention Rate to evaluate our ongoing operations and for internal planning and forecasting purposes. Acquired businesses are included in the last-twelve-month Net Revenue Retention Rate in the ninth quarter after acquisition, which is the earliest point that comparable post-acquisition invoices are available for both the current and prior twelve-month period.
Customer Count with >$100,000 of Revenue
We regularly monitor and review our count of clients who generate more than $100,000 of revenue.
Our count of clients who generate more than $100,000 of revenue is based on an accumulation of the amounts invoiced to clients over the preceding twelve months. The invoices for acquired clients are included starting in the first full calendar quarter after the date of acquisition.
Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, statements regarding Waystar's expectations relating to future operating results and financial position, including full year 2025, and future periods; the performance of our new product offerings; our industry and market opportunities, business strategy, goals, and expectations concerning our market position, future operations, margins and profitability, capital expenditures, liquidity, and capital resources and other financial and operating information. Forward-looking statements include all statements that are not historical facts. These statements may include words such as "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," "outlook," the negative version of these words or similar terms and phrases to identify forward-looking statements in this press release, including the discussion of outlook for full fiscal year 2025.
The forward-looking statements contained in this press release are based on management's current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs, and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management's expectations, beliefs, and projections will result or be achieved. The following factors are among those that may cause actual results to differ materially from the forward-looking statements: our operation in a highly competitive industry; our ability to retain our existing clients and attract new clients; our ability to successfully execute on our business strategies in order to grow; our ability to accurately assess the risks related to acquisitions and successfully integrate acquired businesses; our ability to establish and maintain strategic relationships; the growth and success of our clients and overall healthcare transaction volumes; consolidation in the healthcare industry; our selling cycle of variable length to secure new client agreements; our implementation cycle that is dependent on our clients' timing and resources; our dependence on our senior management team and certain key employees, and our ability to attract and retain highly skilled employees; the accuracy of the estimates and assumptions we use to determine the size of our total addressable market; our ability to develop and market new solutions, or enhance our existing solutions, to respond to technological changes, or evolving industry standards; the interoperability, connectivity, and integration of our solutions with our clients' and their vendors' networks and infrastructures; the performance and reliability of internet, mobile, and other infrastructure; the consequences if we cannot obtain, process, use, disclose, or distribute the highly regulated data we require to provide our solutions; our reliance on certain third-party vendors and providers; any errors or malfunctions in our products and solutions; failure by our clients to obtain proper permissions or provide us with accurate and appropriate information; the potential for embezzlement, identity theft, or other similar illegal behavior by our employees or vendors, and a failure of our employees or vendors to observe quality standards or adhere to environmental, social, and governance standards; our compliance with the applicable rules of the National Automated Clearing House Association and the applicable requirements of card networks; increases in card network fees and other changes to fee arrangements; the effect of payer and provider conduct which we cannot control; privacy concerns and security breaches or incidents relating to our platform; the complex and evolving laws and regulations regarding privacy, data protection, and cybersecurity; our ability to adequately protect and enforce our intellectual property rights; our ability to use or license data and integrate third-party technologies; our use of "open source" software; legal proceedings initiated by third parties alleging that we are infringing or otherwise violating their intellectual property rights; claims that our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties; the heavily regulated industry in which we conduct business; the uncertain and evolving healthcare regulatory and political framework; healthcare laws and data privacy and security laws and regulations governing our processing of personal information; reduced revenues in response to changes to the healthcare regulatory landscape; legal, regulatory, and other proceedings that could result in adverse outcomes; consumer protection laws and regulations; contractual obligations requiring compliance with certain provisions of the Bank Secrecy Act and anti-money laundering laws and regulations; existing laws that regulate our ability to engage in certain marketing activities; our full compliance with website accessibility standards; any changes in our tax rates, the adoption of new tax legislation, or exposure to additional tax liabilities; limitations on our ability to use our net operating losses to offset future taxable income; losses due to asset impairment charges; restrictive covenants in the agreements governing our credit facilities; interest rate fluctuations; unavailability of additional capital on acceptable terms or at all; the impact of general macroeconomic conditions; actions of certain of our significant investors, who may have different interests than the interests of other holders of our securities; and each of the other factors discussed under the heading of "Risk Factors" in the Company's 10K filed with the Securities and Exchange Commission (the "SEC") on February 18, 2025, our prospectus filed with the Securities and Exchange Commission (the "SEC") on June 7, 2024, and in other reports filed with the SEC, all of which are available on the Investor Relations page of our website at investors.waystar.com.
Any forward-looking statements made by us in this press release speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws.
About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.
(1) We have not reconciled the forward-looking adjusted EBITDA, non-GAAP net income, and non-GAAP net income per share guidance included above to the most directly comparable GAAP measure because this cannot be done without
unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses, and certain
fair value measurements, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.
Waystar
Consolidated Statements of Operations
(in thousands, except for share and per share data)
(unaudited)
Three months ended Twelve months ended
December 31, December 31,
2024 2023 2024 2023
Revenue 244,102 206,695 943,549 791,010
Operating expenses
Cost of revenue (exclusive of depreciation
and amortization expenses) 79,542 67,190 315,730 249,767
Sales and marketing 38,990 30,946 156,935 124,437
General and administrative 22,959 16,400 111,753 62,924
Research and development 11,472 9,785 48,775 35,332
Depreciation and amortization 37,996 44,686 186,631 176,467
Total operating expenses 190,959 169,007 819,824 648,927
Income from operations 53,143 37,688 123,725 142,083
Other expense
Interest expense (19,003) (51,262) (141,762) (198,309)
Related party interest expense (1,083) (1,598) (4,508) (7,608)
Income/(loss) before income taxes 33,057 (15,172) (22,545) (63,834)
Income tax expense/(benefit) 13,978 (757) (3,420) (12,500)
Net income/(loss) 19,079 (14,415) (19,125) (51,334)
Net income/(loss) per share:
Basic 0.11 (0.12) (0.13) (0.42)
Diluted 0.11 (0.12) (0.13) (0.42)
Weighted-average shares outstanding:
Basic 172,526,776 121,679,113 149,915,839 121,675,430
Diluted 179,112,559 121,679,113 149,915,839 121,675,430
Waystar
Consolidated Balance Sheets
(in thousands, except for share and per share data)
December 31, December 31,
2024 2023
Assets
Current assets
Cash and cash equivalents 182,133 35,580
Restricted cash 22,449 9,848
Accounts receivable, net of allowance of $5,885 at December 31, 2024 and 145,235 126,089
$5,335 at December 31, 2023
Income tax receivable 2,838 6,811
Prepaid expenses 14,414 13,296
Other current assets 3,972 30,426
Total current assets 371,041 222,050
Property, plant and equipment, net 46,731 61,259
Operating lease right-of-use assets, net 10,820 10,353
Intangible assets, net 1,039,049 1,186,936
Goodwill 3,019,999 3,030,013
Deferred costs 82,815 65,811
Other long-term assets 6,549 6,552
Total assets 4,577,004 4,582,974
Liabilities and stockholders' equity
Current liabilities
Accounts payable 47,365 45,484
Accrued compensation 31,589 23,286
Aggregated funds payable 22,059 9,659
Other accrued expenses 15,930 10,923
Deferred revenue 10,527 10,935
Current portion of long-term debt 11,311 17,454
Related party current portion of long-term debt 357 529
Current portion of operating lease liabilities 5,591 4,398
Current portion of finance lease liabilities 904 821
Total current liabilities 145,633 123,489
Long-term liabilities
Deferred tax liability 100,523 174,480
Long-term debt, net, less current portion 1,185,411 2,134,920
Related party long-term debt, net, less current portion 35,211 64,758
Operating lease liabilities, net of current portion 13,133 14,278
Finance lease liabilities, net of current portion 11,290 12,194
Deferred revenue - LT 5,739 6,173
Other long-term liabilities 278 2,750
Total liabilities 1,497,218 2,533,042
Commitments and contingencies (Note 20)
Stockholders' equity
Preferred stock $0.01 par value - 100,000,000 and zero shares authorized as of
December 31, 2024 and December 31, 2023, respectively; zero shares issued or
outstanding as of December 31, 2024 and December 31, 2023, respectively -
Common stock $0.01 par value - 2,500,000,000 and 227,000,000 shares
authorized at December 31, 2024 and December 31, 2023, respectively;
172,108,240 and 121,679,902 shares issued and outstanding at December 31,
2024 and December 31, 2023, respectively 1,722 1,217
Additional paid-in capital 3,298,083 2,234,688
Accumulated other comprehensive income (loss) 881 15,802
Accumulated deficit (220,900) (201,775)
Total stockholders' equity 3,079,786 2,049,932
Total liabilities and stockholders' equity 4,577,004 4,582,974
Waystar
Consolidated Statements of Cash Flows
(in thousands)
Twelve months ended
December 31,
2024 2023
Cash flows from operating activities
Net loss (19,125) (51,334)
Adjustments to reconcile net income/(loss) to net cash
provided by operating activities
Depreciation and amortization 186,631 176,467
Stock-based compensation 54,437 8,848
Provision for bad debt expense 2,669 2,419
Loss on extinguishment of debt 20,611 393
Deferred income taxes (59,135) (61,665)
Amortization of debt discount and issuance costs 3,946 10,471
Other (99) 485
Changes in:
Accounts receivable (21,816) (16,714)
Income tax refundable 3,973 (2,459)
Prepaid expenses and other current assets (2,322) (9,705)
Deferred costs (16,497) (14,189)
Other long-term assets (472) (1,664)
Accounts payable and accrued expenses 18,228 11,920
Deferred revenue (842) (167)
Operating lease right-of-use assets and lease liabilities (419) (1,691)
Other long-term liabilities - 45
Net cash provided by operating activities 169,768 51,460
Cash flows from investing activities
Purchase of property and equipment and capitalization of internally (27,268) (21,517)
developed software costs
Acquisitions, net of cash and cash equivalents acquired - (40,000)
Net cash used in investing activities (27,268) (61,517)
Cash flows from financing activities
Change in aggregated funds liability 12,399 2,105
Proceeds from equity offering, net of underwriting discounts 1,017,074
Payments of third-party IPO issuance costs (3,407)
Repurchase of shares (844) (688)
Proceeds from exercise of common stock options 1,683 425
Proceeds from issuances of debt, net of creditor fees 576,060 20,000
Payments on debt (1,584,080) (37,983)
Third-party fees paid in connection with issuance of new debt (1,410) (219)
Finance lease liabilities paid (821) (791)
Net cash provided by (used in) financing activities 16,654 (17,151)
Increase in cash and cash equivalents during the period 159,154 (27,208)
Cash and cash equivalents and restricted cash - beginning of period 45,428 72,636
Cash and cash equivalents and restricted cash - end of period 204,582 45,428
Supplemental disclosures of cash flow information
Interest paid 122,771 193,003
Cash taxes paid (refunds received), net 51,100 51,449
Non-cash investing and financing activities
Fixed asset purchases in accounts payable 283 1,091
Unpaid third-party IPO issuance costs 15
Reconciliation of Balance Sheet Cash Accounts to Cash Flow Statement
Balance sheet
Cash and cash equivalents 182,133 35,580
Restricted cash 22,449 9,848
Total 204,582 45,428
Waystar
Reconciliation of Adjusted EBITDA
(in thousands)
(unaudited)
Three months ended Twelve months ended
December 31, December 31,
2024 2023 2024 2023
Net income/(loss) 19,079 (14,415) (19,125) (51,334)
Interest expense 20,086 52,860 146,270 205,917
Income tax expense/(benefit) 13,978 (757) (3,420) (12,500)
Depreciation and amortization 37,996 44,686 186,631 176,467
Stock-based compensation expense 7,037 2,343 54,437 8,848
Acquisition and integration costs 163 711 859 3,947
Costs related to amended debt agreements 1,262 393 14,138 393
IPO related costs 26 423 2,140 1,977
Other (a) 526 1,566
Adjusted EBITDA 100,153 86,244 383,496 333,715
Revenue 244,102 206,695 943,549 791,010
Net income/(loss) margin 7.8 % -7.0 % -2.0 % -6.5 %
Adjusted EBITDA margin 41.0 % 41.7 % 40.6 % 42.2 %
(a) Adjustments relate to additional lease costs due to the relocation of
our Louisville office
Waystar
Reconciliation of Non-GAAP Operating Expenses
(in thousands)
(unaudited)
Three months
ended Twelve months ended
December 31, December 31,
2024 2023 2024 2023
Cost of revenue (exclusive of depreciation and
amortization expenses) 79,542 67,190 315,730 249,767
Less:
Stock-based compensation expense (242) (100) (2,403) (645)
Acquisition and integration costs - 45 (31) (13)
IPO related costs - (9)
Other (a) (33) (33)
Cost of revenue (exclusive of depreciation and
amortization expenses), adjusted 79,267 67,135 313,254 249,109
Sales and marketing 38,990 30,946 156,935 124,437
Less:
Stock-based compensation expense (1,482) (479) (12,440) (1,865)
Acquisition and integration costs - (17) (66)
IPO related costs (7) (15) (148) (15)
Sales and marketing, adjusted 37,501 30,435 144,347 122,491
General and administrative 22,959 16,400 111,753 62,924
Less:
Stock-based compensation expense (4,245) (1,405) (31,288) (5,035)
Acquisition and integration costs (157) (597) (429) (3,304)
Costs related to amended debt agreements (1,262) (393) (14,138) (393)
IPO related costs (19) (393) (1,975) (1,947)
Other (a) (493) (1,533)
General and administrative, adjusted 16,783 13,612 62,390 52,245
Research and development 11,472 9,785 48,775 35,332
Less:
Stock-based compensation expense (1,068) (359) (8,306) (1,303)
Acquisition and integration costs (6) (142) (399) (564)
IPO related costs - (15) (8) (15)
Research and development, adjusted 10,398 9,269 40,062 33,450
Depreciation and amortization 37,996 44,686 186,631 176,467
Less:
Other (a) (2,103) (17,879)
Intangible amortization (b) (30,647) (39,004) (147,887) (159,406)
Depreciation and amortization, adjusted 5,246 5,682 20,865 17,061
Income tax expense/(benefit) 13,978 (757) (3,420) (12,500)
Plus:
Tax effect of adjustments 8,770 9,004 50,170 36,660
Income tax expense/(benefit), adjusted 22,748 8,247 46,750 24,160
(a) Adjustments relate to additional lease costs and accelerated depreciation due to the
relocation of our Louisville office
(b) Intangible amortization relates to acquisitions and therefore included in reconciliation.
Waystar
Reconciliation of Non-GAAP Net Income
(in thousands, except share and per share amounts)
(unaudited)
Three months ended Twelve months ended
December 31, December 31,
2024 2023 2024 2023
Net income/(loss) 19,079 (14,415) (19,125) (51,334)
Stock based compensation 7,037 2,343 54,437 8,848
Acquisition and integration costs 163 711 859 3,947
Costs related to amended debt agreements 1,262 393 14,138 393
IPO related costs 26 423 2,140 1,977
Other (a) 2,629 19,445
Intangible amortization (b) 30,647 39,004 147,887 159,406
Tax effect of adjustments (8,770) (9,004) (50,170) (36,660)
Non-GAAP net income/(loss) 52,073 19,455 169,611 86,577
Non-GAAP net income/(loss) per common share, basic 0.30 0.16 1.13 0.71
Non-GAAP net income/(loss) per common share, diluted 0.29 0.15 1.09 0.68
Weighted average shares used in computing basic Non- 172,526,776 121,679,113 149,915,839 121,675,430
GAAP net income/(loss) per share
Weighted average shares used in computing diluted
Non-GAAP net income/(loss) per share
179,112,559 127,303,675 155,677,094 126,888,989
(a) Adjustments relate to additional lease costs and accelerated depreciation due to the
relocation of our Louisville office
(b) Intangible amortization relates to acquisitions and therefore included in reconciliation.
Waystar
Reconciliation of Unlevered Free Cash Flow
(in thousands)
(unaudited)
Three months
ended Twelve months ended
December 31, December 31,
2024 2023 2024 2023
Net cash provided by operating activities 64,770 11,456 169,768 51,460
Interest paid 21,582 49,318 122,771 193,003
Purchase of property and equipment and (6,224) (5,791) (27,268) (21,517)
capitalization of internally developed software costs
Unlevered free cash flow 80,128 54,983 265,271 222,946
Waystar
Reconciliation of Net Debt
(in thousands)
(unaudited)
December 31, 2024 December 31,
2023
First lien term loan facility outstanding debt, current 11,668 17,983
First lien term loan facility outstanding debt, net of current portion 1,151,878 1,712,833
Second lien term loan facility outstanding debt - 448,000
Receivables facility outstanding debt 80,000 70,000
Cash and cash equivalents (182,133) (35,580)
Net debt 1,061,413 2,213,236
Trailing Twelve Months Adjusted EBITDA 383,496 333,715
Adjusted Gross leverage ratio
3.2x
6.7x
Adjusted Net leverage ratio
2.8x
6.6x
Waystar
Reconciliation of Trailing Twelve Months (TTM) Adjusted EBITDA
(in thousands)
(unaudited)
Three Months Ended TTM
December 31, September
30, June 30, March 31, December 31,
2024 2024 2024 2024 2024
Net income/(loss) 19,079 5,413 (27,685) (15,932) (19,125)
Interest expense 20,086 18,459 50,541 57,184 146,270
Income tax expense/(benefit) 13,978 3,274 (14,611) (6,061) (3,420)
Depreciation and amortization 37,996 60,185 44,276 44,174 186,631
Stock-based compensation expense 7,037 7,903 36,969 2,528 54,437
Acquisition and integration costs 163 188 206 302 859
Costs related to amended debt agreements 1,262 106 2,368 10,402 14,138
IPO related costs 26 109 1,841 164 2,140
Other (a) 526 1,040 1,566
Adjusted
EBITDA 100,153 96,677 93,905 92,761 383,496
(a) Adjustments relate to additional lease costs due to the relocation of
our Louisville office
Media Contact
Kristin Lee
kristin.lee@waystar.com
Investor Contact
Sandy Draper
investors@waystar.com
502-238-9511
View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-reports-fourth-quarter-and-fiscal-year-2024-results-302378383.html
SOURCE Waystar
